This video demonstrates a technique to manufacture chimeric antigen receptor (CAR) T cells ex vivo. Human T cells are incubated with magnetic beads coated with anti-CD3 and anti-CD28 antibodies, along with a medium supplemented with interleukin-2 (IL-2), leading to T cell activation and proliferation. Transgenic lentiviral vectors are introduced, allowing the transgenic RNA to integrate into the host genome and express the transgene. This results in the transduced T cells expressing chimeric antigen receptors (CARs) on their surface. The T cells are harvested at defined time points to assess CAR expression and cryopreservation.
Protocol
All procedures involving sample collection have been performed in accordance with the institute's IRB guidelines.
1. T Cell Activation, Transduction, and Expansion
Activate fresh or cryopreserved primary human T cells by mixing with anti-CD3/CD28 magnetic beads (e.g., dynabeads) at a ratio of 3 beads per T cell in 6-well cell culture dishes. Culture T cells in X-VIVO 15 medium supplemented with 5% normal human AB serum, 2 mM L-glutamine, 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), and interleukin 2 (IL2, 100 units/mL). Maintain T cells at a concentration of 106 T cells/mL during expansion. Culture T cells at 37 °C, 20% O2, and 95% humidity with 5% CO2.
After overnight stimulation, add lentiviral supernatant to activated T cells. Calculate the volume of supernatant necessary to achieve a multiplicity of infection (MOI) of 3−5. NOTE: The CD19-BBζ CAR lentivirus plasmid consists of a CD8 hinge, 4-1BB costimulatory domain, and CD3ζ signaling domain. CD19-BBζ lentiviral supernatant was generated as previously described.
On day 3, collect a representative aliquot of cells for cryopreservation. Prior to cryopreservation, remove the magnetic beads by gentle pipetting and magnetic separation. Prepare a freezing medium containing phosphate-buffered saline (PBS) with 0.5% dimethyl sulfoxide (DMSO) and store at 4 °C until use.
Centrifuge T cells at 300 x g for 5 min. Discard the supernatant and add 5 mL of PBS. Centrifuge cells at 300 x g for 5 min and discard the PBS.
Resuspend the cell pellet in 1 mL of cold cryopreservation medium. Freeze T cells in a chilled freezing container and store at -80 °C for 48 h. Transfer the frozen cells to liquid nitrogen.
Wash the rest of the T cells once in 5 mL of PBS to eliminate the residual vector. Centrifuge at 300 x g for 5 min. Decant the PBS and resuspend the cell pellet in a T cell culture medium at a concentration of 0.5 x 106 cells/mL.
Split the T cells into two cultures, designated for day 5 and day 9. Count T cells by flow cytometry using counting beads (Table of Materials) and monoclonal antibodies to human CD4 and CD8, as well as a viability dye (Table of Materials).
To measure T cell concentration, prepare a master mix containing 500 µL of PBS, 5 µL of counting beads, 10 µL of 7-Amino-actinomycin D cell viability solution, 4 µL of CD4-fluorescein isothiocyanate (FITC) and 4 µL of CD8-allophycocyanin (APC). Add 40 µL of T cells to the master mix and measure cell concentration by flow cytometry based on the number of live T cells/bead counts. Refeed to maintain the cultures at a concentration of 0.5 x 106 cells/mL every other day.
On day 5, count and cryopreserve day 5 cultures as described in steps 1.3 and 1.5.
On day 7, wash 0.5 x 106 T cells in PBS and resuspend in 100 µL of fluorescence-activated cell sorting (FACS) buffer. Detect CAR surface protein expression by immunostaining with a fluorescently-conjugated anti-CAR19 idiotype by flow cytometry.
On day 9, count day 9 cultures and cryopreserve as described in step 1.3.